Evidence map›Paper›PMID 42678438›Full record

ArticleArchives of virology2026

Molecular characterization of a novel partitivirus harboring an additional third dsRNA segment from Trichoderma harzianum.

Jeong Eun Kim, Jeesun Chun, Yo-Han Ko, Dae-Hyuk Kim

Abstract read
In one paragraph

Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeong Eun Kim *Department of Bioactive Material Sciences, Jeonbuk National University, Jeonju, Republic of Korea.
Jeesun Chun *Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju, Republic of Korea.
Yo-Han Ko *Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju, Republic of Korea.
Dae-Hyuk KimDepartment of Bioactive Material Sciences, Jeonbuk National University, Jeonju, Republic of Korea. dhkim@jbnu.ac.kr.

Funding

National Research Foundation of Korea 2022R1A2C3005906
6 · The paper itself

Abstract

We report the complete genome sequence of a novel partitivirus identified from Trichoderma harzianum NFCF092 strain, designated Trichoderma harzianum partitivirus 4 (ThPV4). Unlike canonical members of the family Partitiviridae, which possess a bipartite genome consisting of two double-stranded RNA (dsRNA) segments encoding an RNA-dependent RNA polymerase (RdRP) and a capsid protein (CP), ThPV4 harbors a third dsRNA segment encoding a protein of unknown function. The complete genome consists of dsRNA1 (1,950 bp; encoding the RdRP), dsRNA2 (1,772 bp; encoding the CP), and dsRNA3 (1,629 bp; encoding a protein with unknown function). Sequence analysis shows that each segment possesses a single open reading frame (ORF). The deduced amino acid sequence of the RdRP shows the highest similarity (90.5% identity) to that of Trichoderma gamsii alphapartitivirus 1. Phylogenetic analyses based on the RdRP indicate that ThPV4 clusters within the genus Alphapartitivirus of the family Partitiviridae. To our knowledge. ThPV4 is the first member of the genus Alphapartitivirus identified from T. harzianum to possess an additional, conserved third dsRNA segment.

Indexed as

Double Stranded RNA VirusesFungal VirusesGenome, ViralRNA, Double-StrandedRNA, ViralRNA VirusesTrichodermaAmino Acid SequenceBase SequenceCapsid ProteinsHypocrealesOpen Reading FramesPhylogenyRNA-Dependent RNA PolymeraseSequence Analysis, DNAViral ProteinsCapsid ProteinsRNA-Dependent RNA PolymeraseRNA, Double-StrandedRNA, ViralViral Proteins

Identifiers

PMID42678438
PMCPMC13534193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.